CLINICAL STUDIES

Rheumatoid Arthritis Study

A randomized, double-blind, parallel group, placebo and active controlled, multi-center, phase 3 study of the efficacy and safety of Olokizumab in subjects with Severely or Moderately Active Rheumatoid Arthritis inadequately controlled by Methotrexate Therapy

Study Phase:

Phase 3

Criteria:

  • Male of Female of age 18 years or older
  • Diagnosed with adult-onset Rheumatoid Arthritis
  • Inadequate response to oral, intramuscular, SC and MTX treatment.
Register